|
Myeloid Neoplasia
Citations 61-70 of 176 total displayed.
|
Past content
(since Jan 2009):
|
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
- Long Zhang, Thomas F. Gajewski, and Justin Kline
Blood 2009; 114: 1545-1552.
[Abstract]
[Full text]
[PDF]
Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation
- Ayten Kandilci and Gerard C. Grosveld
Blood 2009; 114: 1596-1606.
[Abstract]
[Full text]
[PDF]
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation
- Yukimasa Shiotsu, Hitoshi Kiyoi, Yuichi Ishikawa, Ryohei Tanizaki, Makiko Shimizu, Hiroshi Umehara, Kenichi Ishii, Yumiko Mori, Kazutaka Ozeki, Yosuke Minami, Akihiro Abe, Hiroshi Maeda, Tadakazu Akiyama, Yutaka Kanda, Yuko Sato, Shiro Akinaga, and Tomoki Naoe
Blood 2009; 114: 1607-1617.
[Abstract]
[Full text]
[PDF]
Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia
- Jerome Tamburini, Alexa S. Green, Valerie Bardet, Nicolas Chapuis, Sophie Park, Lise Willems, Madalina Uzunov, Norbert Ifrah, François Dreyfus, Catherine Lacombe, Patrick Mayeux, and Didier Bouscary
Blood 2009; 114: 1618-1627.
[Abstract]
[Full text]
[PDF]
Analysis of the Ten-Eleven Translocation 2 (TET2) gene in familial myeloproliferative neoplasms
- Cécile Saint-Martin, Gwendoline Leroy, François Delhommeau, Gérard Panelatti, Sabrina Dupont, Chloé James, Isabelle Plo, Dominique Bordessoule, Christine Chomienne, André Delannoy, Alain Devidas, Martine Gardembas-Pain, Françoise Isnard, Yves Plumelle, Olivier Bernard, William Vainchenker, Albert Najman, Christine Bellanné-Chantelot, and the French Group of Familial Myeloproliferative Disorders
Blood 2009; 114: 1628-1632.
[Abstract]
[Full text]
[PDF]
The leukemic stem cell niche: current concepts and therapeutic opportunities
- Steven W. Lane, David T. Scadden, and D. Gary Gilliland
Blood 2009; 114: 1150-1157.
[Abstract]
[Full text]
[PDF]
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
- Jean-Luc Harousseau, Giovanni Martinelli, Wieslaw W. Jedrzejczak, Joseph M. Brandwein, Dominique Bordessoule, Tamas Masszi, Gert J. Ossenkoppele, Julia A. Alexeeva, Gernot Beutel, Johan Maertens, Maria-Belen Vidriales, Hervé Dombret, Xavier Thomas, Alan K. Burnett, Tadeusz Robak, Nuriet K. Khuageva, Anatoly K. Golenkov, Elena Tothova, Lars Mollgard, Youn C. Park, Annick Bessems, Peter De Porre, Angela J. Howes, and for the FIGHT-AML-301 Investigators
Blood 2009; 114: 1166-1173.
[Abstract]
[Full text]
[PDF]
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates
- Damian J. Green, John M. Pagel, Eneida R. Nemecek, Yukang Lin, Aimee Kenoyer, Anastasia Pantelias, Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, Joseph G. Rajendran, Ajay K. Gopal, Steven I. Park, and Oliver W. Press
Blood 2009; 114: 1226-1235.
[Abstract]
[Full text]
[PDF]
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- James W. Vardiman, Jüergen Thiele, Daniel A. Arber, Richard D. Brunning, Michael J. Borowitz, Anna Porwit, Nancy Lee Harris, Michelle M. Le Beau, Eva Hellström-Lindberg, Ayalew Tefferi, and Clara D. Bloomfield
Blood 2009; 114: 937-951.
[Abstract]
[Full text]
[PDF]
Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome
- Ken I. Mills, Alexander Kohlmann, P. Mickey Williams, Lothar Wieczorek, Wei-min Liu, Rachel Li, Wen Wei, David T. Bowen, Helmut Loeffler, Jesus M. Hernandez, Wolf-Karsten Hofmann, and Torsten Haferlach
Blood 2009; 114: 1063-1072.
[Abstract]
[Full text]
[PDF]
|
|
